Israel Confirms Pfizer Vaccine Protects Over 95% Of COVID Infection, Entry And Death.
The Pfizer-BioNtech vaccine provides more than 95% protection against infection, hospitalization and death from COVID-19 , according to a study published this Thursday in The Lancet magazine based on data from Israel’s vaccination campaign. that you have administered only that preparation.
This analysis, based on confidential national data and collected between January 24 and April 3, 2021, is key in the course of the pandemic , since for the first time the effectiveness of the campaign of public vaccination throughout a country.
Keys on the patents of covid-19 vaccines: what are they for? When could the release arrive?
The double dose of Pfizer-BioNTech was shown to be “highly effective” in all age groups – from 16 to those over 85 years old – in preventing symptomatic and asymptomatic transmission of the virus, as well as hospitalizations and death due to disease, according to the study.
Effective at all ages
Protection against COVID is “as strong” among older people as it is among younger adults, according to the study.
The analyzes indicate that the vaccine among people over 85 years of age protects them in 94.1% of infections, 96.9% hospitalization and 97% death from COVID . For their part, vaccinated adults between 16 and 44 years of age avoided contagion in 96.1% of cases and death in 100%.
“A unique and real opportunity”
The use of the Pfizer-BioNtech vaccine (BNT162b2) for 6.5 million inhabitants in Israel was authorized in December 2020 , following laboratory results among those over 16 years of age, at a time when the dominant variant It was the British one (B117).
Israel registered 232,268 cases, 7,694 hospitalizations and 1,113 deaths due to COVID-19 during the analysis period reflected in the study: between January and April 2021.
Moderna says its booster dose is effective against the South African and Brazilian variants of COVID-19
On the day of its conclusion, April 3, 72.1% of the Israeli population had already received at least one of the two doses of the vaccine and was the country with the highest proportion of vaccinated population in the world.
For this reason, the main author of the report and member of the Ministry of Health, Sharon Alroy-Preis, admitted that Israel provides a “unique and real opportunity to determine the effectiveness of the vaccine and to observe the wide effects of the vaccination campaign on the public health”.
Data should not be generalized
These results therefore suggest that vaccination against COVID-19 can help control the pandemic, as has happened in Israel.
However, the study authors warn that these data should not be “generalized” , due to the differences in vaccination campaigns between countries, as well as the evolution of the pandemic and the appearance of new variants in the future, which may cause percentage changes in the effectiveness of the vaccine.
The medical advisor of the Pfizer Vaccines department in the United States, Luis Jodar, assured that it is “urgently necessary” to obtain more data on the effectiveness of the Pfizer-BioNTech vaccine against “serious disease” and “deaths”, as it will be “vital” in tackling the pandemic.